Goldman Sachs cut its crypto ETF exposure in Q1 2026, exiting XRP and Solana funds while trimming Bitcoin and Ether ETFs and reshaping equity bets.

Latest NewsRead More

You might also be interested in reading Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts.